首页> 外国专利> METHOD immunotherapy bone marrow dendritic cell precursors, sensitized tumor cells photomodified IN VIVO, patients with advanced solid tumors

METHOD immunotherapy bone marrow dendritic cell precursors, sensitized tumor cells photomodified IN VIVO, patients with advanced solid tumors

机译:方法免疫疗法骨髓树突状细胞前体,经光敏修饰的INVIVO致敏肿瘤细胞,晚期实体瘤患者

摘要

FIELD: medicine.;SUBSTANCE: invention is related to medicine, oncology, and may be used for antitumor immunotherapy of patients with solid tumors. For this purpose after session of photodynamic therapy of primary tumor or its metastases, autologous bone-marrow precursors of dendrite cells in dose of 3×106 cells/kg of patient weight in 3.5 ml of officinal physiological solution for injections and 1.0 ml of human albumin. Introduction is executed into points intratumorally and along periphery of PDT-modified tumor, also along periphery of affected inguinal lymph nodes and interdigital space of foot or hand by 0.5 ml. The first five introductions are done every day. Then further five introductions are done every three weeks in 2-3 courses.;EFFECT: method makes it possible to activate specific antitumor immunity.;2 ex
机译:技术领域本发明涉及医学,肿瘤学,并且可以用于实体瘤患者的抗肿瘤免疫治疗。为此,在对原发性肿瘤或其转移进行光动力治疗后,在3.5 ml的药用生理溶液中以3×10 6 细胞/ kg体重的剂量使用自体骨髓树突状细胞前体用于注射和1.0 ml人类白蛋白。沿肿瘤内和PDT修饰的肿瘤的周围,以及受影响的腹股沟淋巴结的周围以及足或手的指间间隔进行引入0.5 ml。每天进行前五个介绍。然后每三周在2-3个疗程中进行另外五次介绍。;效果:该方法可以激活特定的抗肿瘤免疫力。2

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号